Dong, Yiyu <br/><br/>
Tumor Xenografts of Human Clear Cell Renal Cell Carcinoma But Not Corresponding Cell Lines Recapitulate Clinical Response to Sunitinib: Feasibility of Using Biopsy Samples.  [electronic resource] 

 -  European urology focus  12 2017 
 - 590-598 p.  digital 
<br/><br/> Publication Type: Evaluation Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2405-4569 
<br/><br/><label>Standard No.: </label>10.1016/j.euf.2016.08.005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Biopsy, Needle<br/>Carcinoma, Renal Cell--drug therapy<br/>Cell Line, Tumor<br/>Feasibility Studies<br/>Female<br/>Heterografts<br/>Humans<br/>Kidney--pathology<br/>Kidney Neoplasms--drug therapy<br/>Male<br/>Mice, Inbred NOD<br/>Mice, SCID<br/>Middle Aged<br/>Random Allocation<br/>Sunitinib--pharmacology<br/>Transplantation, Heterologous<br/>Treatment Outcome<br/>Xenograft Model Antitumor Assays